Monod Bio Receives $1.5M Gates Foundation Grant for TB Diagnostic Development
Seattle startup will use funding to develop urine-based tuberculosis test using engineered NovoBodies technology for low-resource settings.
Read MorePosted by CLP Edit Staff | Sep 8, 2025 | Tuberculosis |
Seattle startup will use funding to develop urine-based tuberculosis test using engineered NovoBodies technology for low-resource settings.
Read MorePosted by CLP Edit Staff | Sep 5, 2025 | POC Rapid Assays |
The test detects early albumin markers in urine within 10 minutes, targeting high-risk diabetes and hypertension patients.
Read MorePosted by CLP Edit Staff | Sep 2, 2025 | Molecular Diagnostic Analyzers |
Johns Hopkins-led study identifies protein signature with 98% accuracy in distinguishing ALS patients from healthy individuals and those with other neurological diseases.
Read MorePosted by CLP Edit Staff | Sep 2, 2025 | Rapid Assays |
Market growth driven by expanding clinical applications and regulatory innovation, with kits and reagents dominating product segments.
Read MorePosted by CLP Edit Staff | Sep 2, 2025 | Coagulation Testing |
The Coag-Sense PT/INR Monitoring System gains IVDR approval for home anticoagulation monitoring, marking the company’s European market entry.
Read More